Knee pain is a common pain associated with the bone structure of knee and is common among all age groups. The knee pain cases in younger patient are majorly caused of physical activity or sports by trauma or overuse. It is caused in the elderly population owing to the wear and tear of the knee joint because of rheumatoid arthritis and osteoarthritis.
MARKET DYNAMICS
High prevalence of arthritis across globe, growing incidence of sports injuries and demand for treatment options for knee pain are the factors driving the growth of global knee pain management market. Development in join replacements and advancements in technology play a crucial role in the growth of global knee pain management market over the forecast period. However, generic competition and high cost of treatment particularly viscosupplementation are the factors hampering the growth of the global knee pain management market.
MARKET SCOPE
The "Knee Pain Management Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of knee pain management market with detailed market segmentation with type and distribution channel. The knee pain management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in knee pain management market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The knee pain management market is segmented on the basis of type and distribution channel. On the basis of type, the knee pain management market is divided into acute knee pain and chronic knee pain. Based on distribution channel, the knee pain management market can be segmented as hospitals pharmacies, retail pharmacies and drug stores, e-commerce and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the knee pain management market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The knee pain management market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyses factors affecting knee pain management market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the knee pain management market in these regions.
MARKET PLAYERS
The report covers key developments in knee pain management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from knee pain management market are anticipated to have lucrative growth opportunities in the future with the rising demand for knee pain management in the global market. Below mentioned is the list of few companies engaged in the knee pain management market.
The report also includes the profiles of key players in knee pain management market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
-Amgen Inc.
-Pfizer Inc.
-Johnson and Johnson
-F. Hoffmann-La Roche AG
-Ferring B.V.
-GlaxoSmithKline plc
-Bayer AG
-AstraZeneca
-Sanofi S.A.
-Zydus Cadila
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.